This episode discusses two MMWR reports. The first highlights ACIP's interim recommendation for the use of the Pfizer-BioNTech COVID-19 Vaccine in children ages 5-11 years. And the second looks at the effectiveness of mRNA vaccination among immunocompromised and immunocompetent adults.

This episode discusses four MMWR reports: two about COVID-19 and two related to lead and other metal exposures in honor of National Lead Poisoning Prevention Week. The first report describes ACIP recommendations for additional primary doses and booster doses of COVID-19 vaccine. The second report looks at infection-induced immunity versus vaccine-induced immunity. The third report examines blood lead levels in children. And the last report explores toxic metals found in some decorative luster dusts used in baking.

This episode discusses three MMWR COVID-19 reports. The first report highlights the effectiveness of COVID-19 vaccination against hospitalization in adolescents. The next report evaluated COVID-19 vaccine safety and found no increased risk of death among COVID-19 vaccine recipients. And the last report describes the proportion of COVID-19 hospitalizations and severe outcomes during the period when Delta became the most common variant.

The first report looks at the safety of an additional dose of COVID-19 vaccine. The next two highlight the association between K-12 school mask policies and pediatric COVID-19 cases. The fourth describes COVID-19-related school closures and disruptions. And the last report looks at trends in anxiety and depression among adults during the pandemic.

This episode discusses four MMWR COVID-19 reports. The first looks at the rate of BMI increase in children during the pandemic. The next report highlights the effectiveness of COVID-19 vaccines by vaccine type. The third examines detailed race data from Hawaii to better understand COVID-19 cases and deaths among the population. The last report looks at COVID symptoms months after a positive test.

This episode discusses six MMWR COVID-19 reports. TThe first three reports look at the effectiveness of COVID-19 vaccines, including during the rise of the Delta variant. The fourth report highlights how untreated wastewater is being used to detect community infection trends. The next report describes the frequency of long-term symptoms of COVID-19, and the last report looks at a modified quarantine policy at a private university in St. Louis.

This episode discusses six MMWR COVID-19 reports. The first report looks at a heart complication that COVID-19 patients are at higher risk of developing. The next two highlight the increase in emergency department visits and hospitalizations among children and adolescents. The next two reports describe a testing program at the University of Texas at Austin and an outbreak following Spring Break 2021 at a university in Chicago. And the last report highlights two linked outbreaks among attendees, staff, and close contacts of a youth camp and a men's conference in Illinois.

This episode discusses six MMWR COVID-19 reports. The first three highlight how easily Delta can spread among people who are unvaccinated and the next two describe how COVID-19 rates remain low when vaccination coverage is high and prevention measures are followed. The last report shows that adults with disabilities were far more likely than adults without disabilities to report serious mental health concerns and substance use during the COVID-19 pandemic.

This episode discusses five MMWR COVID-19 reports. The first three reports highlight the effectiveness of COVID-19 vaccines against infection and hospitalization among adults and nursing home residents. The fourth report describes how there were many more deaths than usual in 2020 and how people from racial and ethnic minority groups were disproportionately affected. The last report shows how rapid antigen testing has been a valuable tool in helping control the spread of COVID-19 in remote areas of Alaska.

This episode discusses two MMWR COVID-19 reports. The first report highlights the benefits of all three FDA-authorized COVID-19 vaccines in preventing COVID-19 infections and hospitalizations. The second report explores alternative methods for analyzing race and ethnicity data for COVID-19 cases and vaccinations.